# What is the difference between triple-negative breast cancer and other types of breast cancer? Canonical page: https://clinicsjo.com/en/faq/difference-triple-negative-breast-cancer-vs-other-types Language: en Category: oncology Publisher: ClinicsJo Published: 2026-09-13T08:09:50.910Z Content updated: 2026-09-13T08:09:50.910Z Translation (ar): https://clinicsjo.com/ar/faq/difference-triple-negative-breast-cancer-vs-other-types Breast cancer is classified based on the presence or absence of specific proteins and receptors on the surface of cancer cells, which act as switches controlling how the tumor grows and spreads [\[1\]](). To understand the difference between triple-negative breast cancer (TNBC) and other types, one must look at the routine tests performed on tumor samples to determine the nature of the disease. ## Biological Differences and Receptors Most breast cancer types rely on three key biomarkers to determine the treatment path: estrogen receptors (ER), progesterone receptors (PR), and the human epidermal growth factor receptor 2 (HER2) protein [\[1\]](). In other common types, one or more of these receptors are present in abundance, allowing doctors to use targeted therapies: - **Hormone Receptor-Positive Types (ER/PR Positive):** These cells use hormones as fuel for growth and respond effectively to hormonal treatments that block these hormones [\[1\]](). - **HER2-Positive Types:** These cells secrete excess amounts of the HER2 protein, which enhances their proliferation, and they can be treated with specialized drugs that specifically target this protein [\[1\]](). In contrast, this type is called "triple-negative" because tissue tests do not reveal the presence of these three receptors (ER, PR, and HER2) [\[1\]](). This means the cancer grows and spreads through mechanisms that do not depend on hormones or the HER2 protein, making it biologically distinct from other types that can be controlled by these means. ## Treatment Challenges and Available Options Given that triple-negative breast cancer does not respond to hormonal therapies or HER2-targeted drugs, treatment primarily focuses on other strategies [\[1\]](). Key options include the following: - **Chemotherapy:** This remains the cornerstone of managing this type and is used to shrink tumors or eliminate remaining cells after surgery [\[1\]](). - **Surgery:** Removing the tumor (lumpectomy) or the entire breast as part of a tumor control plan [\[1\]](). - **Radiation Therapy:** To reduce the likelihood of tumor recurrence in the affected area [\[1\]](). These options are critical, and for more details regarding the complexities of this condition, you can review [Triple-Negative Breast Cancer: Diagnostic Challenges and Modern Treatment Options (Arabic)](). ## Indicators Requiring Medical Attention Regardless of the type of cancer, there are signs indicating the need for urgent medical evaluation, as early diagnosis changes the trajectory of the prognosis. You should consult specialists immediately if you notice any of the following symptoms: a new lump or thickening in the breast or under the arm, sudden changes in the size or shape of the breast, skin dimpling or an orange-peel appearance, abnormal nipple discharge, or any changes in the color and skin of the breast [\[1\]](). After any diagnosis, a precise follow-up plan is required, including regular screenings to detect any abnormal activity. The patient must immediately inform the medical team of any emergency symptoms such as shortness of breath, severe weakness, or fever, which may indicate complications requiring rapid intervention [\[2\]](). ## Medical references - [Breast Cancer]() - [After chemotherapy - discharge]() General health education; not a substitute for individualized clinical assessment. Citation URL: https://clinicsjo.com/en/faq/difference-triple-negative-breast-cancer-vs-other-types#answer